7 hours Ago By ABMN Staff
Marshall Wace LLP cut its stake in shares of Nutex Health Inc. ( NASDAQ:NUTX – Free Report ) by 43.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission.
The firm owned 39,211 shares of the company’s stock after selling 30,345 shares during the quarter. Marshall Wace LLP owned approximately 0.72% of Nutex Health worth $1,243,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in NUTX. American Century Companies Inc. bought a new position in shares of Nutex Health during the 4th quarter valued at approximately $1,362,000.
Drive Wealth Management LLC bought a new position in shares of Nutex Health during the 4th quarter valued at approximately $1,122,000. Essex Investment Management Co. LLC grew its stake in shares of Nutex Health by 45.
4% during the 4th quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company’s stock valued at $3,353,000 after acquiring an additional 33,024 shares during the period.
Russell Investments Group Ltd. bought a new position in shares of Nutex Health during the 4th quarter valued at approximately $672,000. Finally, State Street Corp bought a new position in shares of Nutex Health during the 3rd quarter valued at approximately $225,000.
5.32% of the stock is currently owned by institutional investors. Insider Buying and Selling at Nutex Health In other Nutex Health news, CFO Jon Christian Bates acquired 1,000 shares of the stock in a transaction on Tuesday, April 8th.
The stock was acquired at an average price of $81.81 per share, for a total transaction of $81,810.00.
Following the completion of the transaction, the chief financial officer now directly owns 4,888 shares of the company’s stock, valued at $399,887.28. This trade represents a 25.
72 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink . 38.
52% of the stock is owned by company insiders. Nutex Health Trading Down 12.0 % Nutex Health ( NASDAQ:NUTX – Get Free Report ) last posted its quarterly earnings results on Monday, March 31st.
The company reported $11.12 earnings per share for the quarter, topping the consensus estimate of ($0.09) by $11.
21. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.
09%. The business had revenue of $81.30 million during the quarter, compared to the consensus estimate of $81.
13 million. Wall Street Analysts Forecast Growth Separately, Maxim Group boosted their price objective on Nutex Health from $75.00 to $100.
00 and gave the company a “buy” rating in a research note on Tuesday, April 8th. Get Our Latest Research Report on Nutex Health Nutex Health Profile ( Free Report ) Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate.
The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. Read More Want to see what other hedge funds are holding NUTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutex Health Inc.
( NASDAQ:NUTX – Free Report ). Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter .
.
